NeoGenomics, Inc. (NEO) — Financial statements
Income statement, balance sheet, and cash flow for NeoGenomics, Inc. — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 727↑10.1% | 661↑11.6% | 592↑16.1% | 510↑5.2% | 484 | |
| Cost of Revenue | 445↑20.1% | 370↑6.8% | 347↑7.8% | 322↑8.3% | 297 | |
| Gross Profit | 283↓2.6% | 290↑18.6% | 245↑30.2% | 188↑0.4% | 187 | |
| Operating Expenses | ||||||
| R&D Expenses | 37↑19.0% | 31↑14.1% | 27↓9.9% | 30↑38.6% | 22 | |
| General & Administrative Expenses | 273↑21.0% | 226↑8.0% | 209↓0.7% | 211↓4.9% | 221 | |
| Selling & Marketing Expenses | 92↑8.7% | 85↑19.5% | 71↑5.2% | 67↑7.6% | 63 | |
| SG&A Expenses | 365↑17.7% | 310↑10.9% | 280↑0.7% | 278↓2.1% | 284 | |
| Other Expenses | -54↓232.7% | 41↓10.0% | 45↑20.9% | 37 | 0.00 | |
| Operating Expenses | 349↓8.8% | 382↑8.5% | 352↑2.0% | 346↑13.0% | 306 | |
| Total Costs & Expenses | 793↑5.4% | 753↑7.6% | 699↑4.8% | 667↑10.7% | 603 | |
| Operating Results | ||||||
| Operating Income | -66↑28.3% | -92↑14.5% | -108↑31.6% | -158↓32.7% | -119 | |
| Depreciation & Amortization | 68↓6.5% | 73↓0.0% | 73↑4.5% | 69↑30.1% | 53 | |
| EBITDA | 2↑215.5% | -2↑91.4% | -18↑78.6% | -82↓25.9% | -65 | |
| EBIT | -66↑10.8% | -74↑17.9% | -90↑40.6% | -152↓27.8% | -119 | |
| Interest & Other Income | ||||||
| Net Interest Income | 5↓55.0% | 12↑18.2% | 10↑763.7% | -2↑70.4% | -5 | |
| Interest Income | 9↓50.8% | 18↑9.0% | 17↑178.2% | 6↑93.6% | 3 | |
| Interest Expense | 4↓43.3% | 7↓4.2% | 7↓8.9% | 8↓7.8% | 8 | |
| Non-Operating Income | 0.00↑100.0% | -18↓2.9% | -18↓199.3% | -6 | 0.00 | |
| Other Income / Expenses | -44↓486.6% | 11↑7.4% | 11↑718.9% | -2↓101.7% | 104 | |
| Income Before Tax | -110↓36.7% | -81↑16.9% | -97↑39.1% | -159↓957.0% | -15 | |
| Income Tax Expense | -2↓15.1% | -2↑78.7% | -9↑39.5% | -15↓124.3% | -7 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | -108↓37.2% | -79↑10.5% | -88↑39.0% | -144↓1628.2% | -8 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | -108↓37.2% | -79↑10.5% | -88↑39.0% | -144↓1628.2% | -8 | |
| Bottom-Line Net Income | -108↓37.2% | -79↑10.5% | -88↑39.0% | -144↓1628.2% | -8 | |
| EPS (Basic) | -4.20↓35.5% | -3.10↑11.4% | -3.50↑39.7% | -5.80↓1557.1% | -0.35 | |
| EPS (Diluted) | -4.20↓35.5% | -3.10↑11.4% | -3.50↑39.7% | -5.80↓1557.1% | -0.35 | |
| Weighted Average Shares | 26↑1.1% | 25↑0.9% | 25↑1.0% | 25↑3.5% | 24 | |
| Weighted Average Diluted Shares | 26↑1.1% | 25↑0.9% | 25↑1.0% | 25↑3.5% | 24 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.